Stable Glaucoma Monitoring Service - CAN

CPV: Ophthalmologist services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

4 Aug 2026, 14:35 BST

Last source update

4 Aug 2026, 14:35 BST

FTS notice number

2026/S 000-073755

Classification (CPV)

Ophthalmologist services

Delivery area

South East (UKJ25)

Official registry OCID

ocds-h6vhtk-06db67 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C.

Publisher note: This contract is awarded via Direct Award Process C, in accordance with The Health Care Services (Provider Selection Regime) Regulations 2023 (PSR). The authority confirms the provider delivered the prior contract to a consistently high standard and no material changes have been made in the renewed contracting arrangement. Against the Provider Selection Regime (PSR) Key Criteria, Dorking Healthcare Ltd (DHC) has demonstrated expertise and is anticipated to continue doing so. Evidence of current service delivery against the PSR Key Criteria and the breakdown of Key Criteria weighting in relation to this service for the purposes of awarding a contract under Direct Award C is detailed below: Quality & Innovation (20%) • DHC has consistently delivered a safe, high-quality, and effective Stable Glaucoma Monitoring (SGM) service under the previous contract. The service is clinically led by a suitably accredited GPwSI, with oversight maintained through a robust clinical governance framework. • The model incorporates a structured patient pathway with 6-12-month reviews in a 4-visit cycle, including 3 appointments with accredited optometrists and 1 with a GPwSI or consultant. All practitioners are accredited in accordance with Royal College of Ophthalmologists and local ICB requirements, with annual evidence of revalidation or CPD submitted. • Innovation is embedded in DHC's approach through enhanced IT integration, use of optical coherence tomography (OCT) where clinically indicated, and responsive service adjustments based on patient experience. DHC also maintains clinical mentorship links with acute ophthalmology services, ensuring high standards of clinical care are maintained within the community. Integration, Collaboration & Sustainability (25%) • DHC operates a service that is fully integrated within Surrey Downs' community and primary care pathways. The service complements tier 3 ophthalmology services and provides a critical interface with primary care optometry, reducing demand on acute outpatient services. • DHC engages regularly with local system partners including GPs, the Local Optical Committee (LOC), and the ICB to ensure the service reflects changing population needs and demand pressures. This supports sustainable models of care and system resilience, especially during peak elective recovery periods. • By delivering care in community settings, DHC contributes to the ICB's sustainability agenda by reducing reliance on high-cost acute services and supporting the NHS's Net Zero commitments through reduced patient travel and emissions. Improving access, reducing health inequalities and facilitating choice 25% • DHC's SGM service enhances access to specialist eye care by providing appointments locally, including flexible scheduling options, reduced waiting times, and easier accessibility for patients who may experience barriers to attending hospital-based services. • This community model ensures a more equitable service offer, supporting underserved patient cohorts including older adults, those with long-term conditions, or those in rural or transport-challenged areas. The service offers choice and convenience, contributing to better engagement and earlier identification of progression risks. • By diverting appropriate patients from secondary care, DHC enables those with complex needs to be seen more quickly by acute services, thereby reducing inequality in waiting times and improving system-wide equity. Value (20%) • DHC delivers demonstrable value for money by providing specialist eye care in a lower-cost, community-based setting. This reduces secondary care outpatient follow-ups, supporting the ICB in achieving system savings and better use of specialist resources. • The service ensures timely patient follow-up, reducing the clinical risk associated with delayed reviews in glaucoma patients. Outcomes are monitored through Local Quality Requirements (LQRs) and activity-based reporting to ensure transparency, accountability, and continuous improvement. • DHC's ability to deliver at a stable unit cost while maintaining high-quality care and system benefits reinforces its value as a trusted partner. Social Value (10%) • DHC's delivery of the Stable Glaucoma Monitoring (SGM) service contributes significantly to social value in alignment with NHS England's Social Value Model and the ICB's commitment to community-based, patient-centred care. • The service offers improved local access to ophthalmic care, reducing the need for hospital visits and associated patient travel, which lowers carbon emissions and supports environmental sustainability. Appointments delivered within the community enable earlier interventions and better long-term health outcomes for patients, particularly those with mobility challenges or in underserved areas. This aligns with NHS goals to reduce health inequalities and promote fairer access. • DHC recruits, trains, and retains local staff, contributing to employment, skill development, and economic sustainability within the Surrey Downs area. The organisation also fosters collaboration with local primary care services and integrates care pathways to reduce demand on acute settings. This supports the broader system's resilience and encourages partnership working across the ICS. • Through regular patient feedback, DHC continues to shape the service to meet community needs, enhancing patient experience and empowerment. Their person-centred approach helps address wider determinants of health while ensuring care is safe, timely, and effective. Conflicts of Interest: All Decision-Making Forums requested that Conflicts of Interest be declared in order to accommodate mitigations that may be required. No declarations were raised. Individuals working on the programme declared no interests for the duration. Governance and Decision-Making Approval: Surrey and Sussex ICB Commissioning Group recommendation - 12th May 2026 Surrey and Sussex ICB Executive Committee approval - May 2026

• Dorking Healthcare LimitedAwarded supplierGB-COH: 06927650 The Surgery, Tanners Meadow, Brockham, South East, RH3 7NJ

No document links were published on the notice.